Cadrenal Therapeutics, Inc.
For the period ended Sep 24, 2026. Filed Aug 3, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Sep 24, 2026 · Filed Aug 3, 2026
CVKD$0.98-2.0%Stored close · as of Nov 6, 2026
Contents
PROXY STATEMENT
For the 2026 Annual Meeting of Stockholders to be held on September 24, 2026
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.